Among them, cell cycle inhibitors, including Smads and CDKNs, were down-regulated while CDKs, CCNs, E2Fs ATM, ATR, ERCC6, MCMs, and BRCA1 were up-regulated (Fig. 4C), consistent with a tumor-promoting effect (Fig. 4C). This evidence concerns the gene BRCA1 and neoplasm.